Washington PostHigh hopes & hype for experimental depression drug ketamineWashington PostLast year, Sanacora co-authored an American Psychiatric Association task force review of ketamine treatment for mood disorders that noted the benefits but said “major gaps” remain in knowledge about long-term effectiveness and safety. Most studies have ...and more »